Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas

Leukemia Research

Volumn 37, Issue 6, 2013, Pages 619-623

  Bari, Alessia ^a   Tadmor, Tamar ^b   Sacchi, Stefano ^a   Marcheselli, Luigi ^a   Liardo, Eliana Valentina ^a   Pozzi, Samantha ^a   Luminari, Stefano ^a   Baldini, Luca ^c   Marmiroli, Sandra ^a   Federico, Massimo ^a   Polliack, Aaron ^d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF MILAN   (Italy)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Monocytosis; Non Hodgkin lymphoma; Overall survival; Peripheral T cell lymphoma; Prognostic value

Indexed keywords

ALBUMIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONOCYTOSIS; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STUDY; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEUKOCYTOSIS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MONOCYTES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84877083904     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.01.009     Document Type: Article

References (36)

1. Armitage J.O. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012, 87:511-519.
2. Jaffe E.S. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009, 523-531.
3. Project TN-HsLC A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 1997, 89:3909-3918.
4. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987-94.
5. Gallamini A., Stelitano C., Calvi R., et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004, 103:2474-2479.
6. Went P., Agostinelli C., Gallamini A., et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006, 24:2472-2479.
7. Weisenburger D.D., Savage K.J., Harris N.L., et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 2011, 117:3402-3408.
8. Lenz G., Wright G., Dave S.S., et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008, 359:2313-2323.
9. Iqbal J., Weisenburger D.D., Greiner T.C., et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010, 115:1026-1036.
10. Ishida T., Inagaki H., Utsunomiya A., et al. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res 2004, 10:5494-5500.
11. Kitagawa J., Hara T., Tsurumi H., et al. Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U). J Cancer Res Clin Oncol 2009, 135:53-59.
12. Kim Y.R., Kim J.S., Kim S.J., et al. Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy. J Hematol Oncol 2011, 4:34.
13. Castillo J.J., Morales D., Quinones P., Cotrina E., Desposorio C., Beltran B. Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma 2010, 51:1822-1828.
14. Mitrovic Z., Perry A.M., Suzumiya J., et al. The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. Am J Hematol 2012, 87:790-794.
15. Chihara D., Oki Y., Ine S., et al. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy. Leuk Lymphoma 2009, 50:1999-2004.
16. Wilcox R.A., Ristow K., Habermann T.M., et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 2011, 25:1502-1509.
17. Tadmor T., Mishchenko E., Schliamser L., Laor R., Polliack A., Attias D. Peripheral blood monocytosis is an independent prognostic factor for survival in diffuse large B cell lymphoma (DLBCL). Ann Oncol 2011, 22(Suppl. 4). iv223 [abstracts 441].
18. Porrata L.F., Ristow K., Habermann T.M., et al. Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma. Leuk Lymphoma 2012, 53(11):2159-2165.
19. Wilcox R.A., Ristow K., Habermann T.M., et al. The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma 2012, 53:575-580.
20. Porrata L.F., Ristow K., Colgan J.P., et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin lymphoma. Haematologica 2012, 97(2):262-269.
21. Lindholm P.F., Lu Y., Adley B.P., et al. Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression. Prostate 2010, 70:1672-1682.
22. Coffelt S.B., Hughes R., Lewis C.E. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 2009, 1796:11-18.
23. Tadmor T., Attias D., Polliack A. Myeloid-derived suppressor cells - their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Br J Haematol 2011, 153:557-567.
24. Lin Y., Gustafson M.P., Bulur P.A., Gastineau D.A., Witzig T.E., Dietz A.B. Immunosuppressive CD14+HLA-DRlow/-monocytes in B-cell non-Hodgkin lymphoma. Blood 2011, 117:872-881.
25. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 457-481.
26. Cox D. Regression models and life tables. J Roy Stat Soc Ser. B Method 1972, 34:187-220.
27. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982, 69:239-241.
28. Fleming T.R., Harrington D.P., O'Sullivan M. Supremum versions of the log-rank and generalized Wilcoxon statistics. J Am Stat Assoc 1987, 82:312-320.
29. Tadmor T., Benyamini N., Avivi I., et al. Absolute Monocyte count is associated with adverse prognosis in diffuse large B-cell lymphoma: a validation study in a cohort of 219 patients from two centers. Haematologica 2012, 97(s1):127. [abstract 0318].
30. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO Classification of tumors of haematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer, Lyon, France. 4th edition.
31. Vose J.M. The International PTCL Project, International Peripheral T-Cell Lymphoma (PTCL) Clinical and Pathologic Review Project: Poor Outcome by Prognostic Indices and Lack of Efficacy with Anthracyclines. Blood (ASH Annual Meeting) 2005, 106:811.
32. Gutiérrez-García G., García-Herrera A., Cardesa T., et al. Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol 2011, 22:397-404.
33. Tokioka T., Shimamoto Y., Motoyoshi K., Yamaguchi M. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma. Haematologia (Budap) 1994, 26:1-9.
34. Takasaki Y., Iwanaga M., Tsukasaki K., et al. Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL). Leuk Res 2007, 31:751-757.
35. Wilcox R.A., Wada D.A., Ziesmer S.C., et al. Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood 2009, 114:2936-2944.
36. Bari A., Marcheselli L., Sacchi S., et al. Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann Oncol 2010, 21:1486-1491.